Aranesp (TM) (darbepoetin alfa) administered once every other week treats anemia in patients with chronic kidney disease (CKD) not receiving renal replacement therapy. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • September 1, 2002